Neihulizumab (ALTB-168), an immune checkpoint agonistic antibody, targets and binds to human CD162 (PSGL-1), resulting in the downregulation of activated T-cells. It is utilized in research aimed at treating steroid-refractory acute graft-versus-host dis
CAS Number:
[2158362-38-8]
* VAT and and shipping costs not included. Errors and price changes excepted